BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22313300)

  • 1. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.
    Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L
    Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells.
    Amin KM; Abou-Seri SM; Awadallah FM; Eissa AA; Hassan GS; Abdulla MM
    Eur J Med Chem; 2015 Jan; 90():221-31. PubMed ID: 25461322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety.
    Han X; Yu YL; Ma D; Zhang ZY; Liu XH
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):344-360. PubMed ID: 33356666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
    Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
    Venkateswararao E; Sharma VK; Manickam M; Yun J; Jung SH
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5256-9. PubMed ID: 25442319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new chromen-4-one derivatives as telomerase inhibitors through regulating expression of dyskerin.
    Quan Wang J; Di Yang M; Chen X; Wang Y; Zeng Chen L; Cheng X; Hua Liu X
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1199-1211. PubMed ID: 30132373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
    Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
    Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
    Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.
    Chen X; Zha GF; Wang JQ; Liu XH
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones.
    Huang W; Ding Y; Miao Y; Liu MZ; Li Y; Yang GF
    Eur J Med Chem; 2009 Sep; 44(9):3687-96. PubMed ID: 19410339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo.
    Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ
    Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
    Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
    Shi JB; Tang WJ; Qi XB; Li R; Liu XH
    Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Enantiomeric Separation of a Novel Spiroketal Derivative: A Potent Human Telomerase Inhibitor with High in Vitro Anticancer Activity.
    Fuggetta MP; De Mico A; Cottarelli A; Morelli F; Zonfrillo M; Ulgheri F; Peluso P; Mannu A; Deligia F; Marchetti M; Roviello G; Reyes Romero A; Dömling A; Spanu P
    J Med Chem; 2016 Oct; 59(19):9140-9149. PubMed ID: 27592503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic Liquid-Promoted Synthesis of Novel Chromone-Pyrimidine Coupled Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study and Toxicity Study.
    Tiwari SV; Seijas JA; Vazquez-Tato MP; Sarkate AP; Karnik KS; Nikalje APG
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29462951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
    Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.